Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas (original) (raw)

References

  1. Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467–1475.
    Article CAS Google Scholar
  2. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A . Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313–318.
    Article CAS Google Scholar
  3. de Leval L, Savilo E, Longtine J, Ferry JA, Harris NL . Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol 2001; 25: 395–400.
    Article CAS Google Scholar
  4. Pogue SL, Kurosaki T, Bolen J, Herbst R . B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J Immunol 2000; 165: 1300–1306.
    Article CAS Google Scholar
  5. Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 2006; 132: 303–316.
    Article CAS Google Scholar
  6. Gururajan M, Dasu T, Shahidain S, Jennings CD, Robertson DA, Rangnekar VM et al. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J Immunol 2007; 178: 111–121.
    Article CAS Google Scholar
  7. Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230–2237.
    Article CAS Google Scholar
  8. Turner M, Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz VL . Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today 2000; 21: 148–154.
    Article CAS Google Scholar
  9. Leseux L, Hamdi SM, Al Saati T, Capilla F, Recher C, Laurent G et al. Syk-dependent mTOR activation in follicular lymphoma cells. Blood 2006; 108: 4156–4162.
    Article CAS Google Scholar
  10. Pozzobon M, Marafioti T, Hansmann ML, Natkunam Y, Mason DY . Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol 2004; 124: 519–533.
    Article CAS Google Scholar
  11. Marafioti T, Pozzobon M, Hansmann ML, Gaulard P, Barth TF, Copie-Bergman C et al. Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia 2005; 19: 856–861.
    Article CAS Google Scholar
  12. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, Camacho FI, Algara P, Martinez N et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005; 106: 1831–1838.
    Article CAS Google Scholar
  13. Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994; 152: 4758–4766.
    CAS PubMed Google Scholar
  14. Pine PR, Chang B, Schoettler N, Banquerigo ML, Wang S, Lau A et al. Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. Clin Immunol 2007; 124: 244–257.
    Article CAS Google Scholar
  15. Jaffe ES, Harris NL, Stein H, Vardiman J . Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon France, 2001, pp 189–235.
    Google Scholar
  16. Remstein ED, Dogan A, Einerson RR, Paternoster SF, Fink SR, Law M et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol 2006; 30: 1546–1553.
    Article Google Scholar
  17. Morice WG, Hanson CA, Kumar S, Frederick LA, Lesnick CE, Greipp PR . Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders. Leukemia 2007; 21: 2043–2046.
    Article CAS Google Scholar
  18. Zhang J, Billingsley ML, Kincaid RL, Siraganian RP . Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J Biol Chem 2000; 275: 35442–35447.
    Article CAS Google Scholar
  19. Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C et al. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther 2005; 4: 1867–1879.
    Article CAS Google Scholar
  20. Weil R, Levraud JP, Dodon MD, Bessia C, Hazan U, Kourilsky P et al. Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines. J Virol 1999; 73: 3709–3717.
    CAS PubMed PubMed Central Google Scholar
  21. Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, Olson S et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005; 36: 494–504.
    Article CAS Google Scholar
  22. Canetti C, Aronoff DM, Choe M, Flamand N, Wettlaufer S, Toews GB et al. Differential regulation by leukotrienes and calcium of Fc gamma receptor-induced phagocytosis and Syk activation in dendritic cells versus macrophages. J Leukoc Biol 2006; 79: 1234–1241.
    Article CAS Google Scholar
  23. Brumbaugh KM, Binstadt BA, Billadeau DD, Schoon RA, Dick CJ, Ten RM et al. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med 1997; 186: 1965–1974.
    Article CAS Google Scholar
  24. Irish JM, Czerwinski DK, Nolan GP, Levy R . Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 2006; 108: 3135–3142.
    Article CAS Google Scholar
  25. Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the MD Anderson Cancer Center experience. Cancer 2005; 103: 2091–2098.
    Article Google Scholar

Download references